NBME-style questions › Chronic Kidney Disease
Chronic Kidney Disease · NBME-Style

Chronic Kidney Disease — NBME-style practice question

A physician-validated, board-style question from the Active Transport QBank. Try it, then check the reasoning for every option.

A 62-year-old woman with type 2 diabetes mellitus comes to the physician because of a 3-month history of fatigue and weakness. Her hemoglobin A1c concentration was 13.5% 12 weeks ago. Her blood pressure is 152/92 mm Hg. Examination shows lower extremity edema. Serum studies show: K+ 5.1 mEq/L Phosphorus 5.0 mg/dL Ca2+ 7.8 mg/dL Urea nitrogen 60 mg/dL Creatinine 2.2 mg/dL Which of the following is the best parameter for early detection of this patient’s renal condition?"

↑ Tap an answer to reveal the reasoning
Answer: C. A patient with longstanding poorly controlled type 2 diabetes (HbA1c 13.5%), hypertension, edema, and laboratory evidence of moderate-to-severe chronic kidney disease (Cr 2.2, BUN 60, hyperkalemia, hyperphosphatemia, hypocalcemia, low eGFR) has diabetic nephropathy - the leading cause of end-stage renal disease in the US. For EARLY DETECTION of diabetic nephropathy - before frank renal dysfunction develops - the screening test is URINARY ALBUMIN EXCRETION (specifically, the urine albumin-to-creatinine ratio on a spot urine sample). Microalbuminuria, defined as 30-300 mg/g of creatinine, is the first detectable renal abnormality in diabetic nephropathy, often present years before serum creatinine rises. Microalbuminuria progresses to overt proteinuria (>300 mg/g) and then to declining GFR. The progression follows: hyperfiltration → microalbuminuria → macroalbuminuria → declining GFR → ESRD. ALL diabetics should be screened annually with a spot urine albumin-creatinine ratio, starting at diagnosis for type 2 diabetes (some glycemic damage may have occurred during the undiagnosed phase) and 5 years after diagnosis for type 1. Detection of microalbuminuria warrants initiation of ACE inhibitor or ARB therapy (regardless of blood pressure), tight glycemic and blood pressure control, and SGLT2 inhibitor or finerenone consideration to slow progression. Key contrasts: red blood cell casts indicate glomerulonephritis (nephritic syndrome) - not diabetic nephropathy. Serum total protein is too non-specific. Serum creatinine rises LATE in diabetic nephropathy and misses the early phase where intervention is most effective. **Why each option:** **A.** Urinary RBC casts indicate glomerulonephritis (nephritic) - not the typical proteinuric (nephrotic-spectrum) presentation of diabetic nephropathy. **B.** Serum total protein is non-specific and changes only with significant proteinuria, hepatic disease, or malnutrition - not useful for early detection. **C.** Correct. Microalbuminuria - measured as urinary albumin-to-creatinine ratio (30-300 mg/g) on a spot sample - is the earliest detectable abnormality in diabetic nephropathy and predates rises in serum creatinine by years. **D.** Serum creatinine rises LATE in diabetic nephropathy after substantial nephron loss; by the time it is elevated, much of the damage is irreversible - it is not an early detection marker.

Want 12,000 more like this?

Practice the full physician-validated NBME-style QBank, matched to your own notes — free for 7 days, no credit card.

Start your free Pro trial →
← Browse more free NBME-style questions